Literature DB >> 19779676

[Differential diagnosis and therapy of gout].

Monika Reuss-Borst1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19779676     DOI: 10.1007/s00063-009-1154-z

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


× No keyword cloud information.
  16 in total

Review 1.  Diagnosis and management of gout.

Authors:  Martin Underwood
Journal:  BMJ       Date:  2006-06-03

2.  Gout is associated with more comorbidities, poorer health-related quality of life and higher healthcare utilisation in US veterans.

Authors:  J A Singh; V Strand
Journal:  Ann Rheum Dis       Date:  2008-01-04       Impact factor: 19.103

3.  Coexistent gout and rheumatoid arthritis. Case report and literature review.

Authors:  D J Wallace; J R Klinenberg; D Morham; B Berlanstein; P C Biren; G Callis
Journal:  Arthritis Rheum       Date:  1979-01

Review 4.  Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review.

Authors:  Chang-Fu Kuo; Wen-Pin Tsai; Lieh-Bang Liou
Journal:  Clin Rheumatol       Date:  2007-12-07       Impact factor: 2.980

Review 5.  [Calcium pyrophosphate dihydrate-crystal induced arthropathy].

Authors:  P Schneider Internist-Rheumatologe Chefarzt Der Abteilung Für Rheumatologie; I Schneider
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

6.  [Gout].

Authors:  W Gröbner; N Zöllner
Journal:  Z Rheumatol       Date:  2004-02       Impact factor: 1.372

7.  Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial.

Authors:  Hein J E M Janssens; Matthijs Janssen; Eloy H van de Lisdonk; Piet L C M van Riel; Chris van Weel
Journal:  Lancet       Date:  2008-05-31       Impact factor: 79.321

8.  Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.

Authors:  H Ralph Schumacher; Michael A Becker; Robert L Wortmann; Patricia A Macdonald; Barbara Hunt; Janet Streit; Christopher Lademacher; Nancy Joseph-Ridge
Journal:  Arthritis Rheum       Date:  2008-11-15

9.  Seasonality and trends in the incidence and prevalence of gout in England and Wales 1994-2007.

Authors:  A J Elliot; K W Cross; D M Fleming
Journal:  Ann Rheum Dis       Date:  2008-11-24       Impact factor: 19.103

10.  Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.

Authors:  Chi Yin Man; Ian T F Cheung; Peter A Cameron; Timothy H Rainer
Journal:  Ann Emerg Med       Date:  2007-02-05       Impact factor: 5.721

View more
  2 in total

1.  [Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia].

Authors:  A-K Tausche; B Manger; U Müller-Ladner; B Schmidt
Journal:  Z Rheumatol       Date:  2012-04       Impact factor: 1.372

Review 2.  Treatment Options for Gout.

Authors:  Bettina Engel; Johannes Just; Markus Bleckwenn; Klaus Weckbecker
Journal:  Dtsch Arztebl Int       Date:  2017-03-31       Impact factor: 5.594

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.